News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
Presentation TCT 2017 Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans Presenter: Elazer R. Edelman, Paul A. Sobotka, Karl-Heinz Kuck October 30, 2017
News Daily News Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies Todd Neale October 19, 2017
News Daily News One in Four ICD Patients Need Reintervention Within 5 Years Ashley Lyles August 04, 2017
News Daily News TAVR Use Triples in France, With Docs Treating Lower-Risk Patients Michael O'Riordan June 26, 2017
News Conference News TVT 2017 Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line Michael O'Riordan June 20, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters Michael O'Riordan May 17, 2017
News Conference News CRT 2017 Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation Michael O'Riordan February 22, 2017
News Daily News Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve Michael O'Riordan February 09, 2017